Unraveling the role of myeloid cells and metabolism in clinical progression of MS

B04

Myeloid cells play an increasingly recognized role in CNS autoimmune conditions such as multiple sclerosis (MS). However, mechanisms that drive disease progression from the relapsing-remitting to the progressive stage and that cause accumulating neurologic damage are far from being definitive. We identified dynamic modes of communication between neurons, CNS-localized myeloid cells and invading T lymphocytes in chronic neuroinflammation. Now, we will link a detailed understanding of the molecular pathways underlying this metabolic communication with a strong translational focus on disease progression. We could demonstrate that enhanced metabolic activity e.g. tissues like tumors or regenerating tissues after injury or during inflammatory processes, promotes an M2-like macrophage phenotype that is orchestrated by the transcription factor ICER in a G protein-coupled receptor (GPCR)- and cAMP-dependent manner (Bohn et al., 2018). We propose that the inflammatory response in the CNS, and accompanying acidification of the tissue, instructs a M2-like tissue repair phenotype in macrophages counteracting neurodegenerative processes and disease progression as an intrinsic defence mechanism of the CNS. To this end, we intend to answer these questions in our working plan:

    1. What is the role of G protein-coupled sensing of acidification and ICER expression in CNS inflammation and disease progression?
    2. What role does the role of ICER in metabolic reprogramming of macrophages and microglia play in CNS inflammation?
    3. What is the role of ICER and GPCR for disease progression in MS patients?


Sekine et al. Nature Immunology, 2018

 

Principal Investigators:

Prof. Dr. med. Stefan Bittner
Department of Neurology, Forschungszentrum Immuntherapie
Mainz
stefan.bittner@unimedizin-mainz.de

Univ.-Prof. Dr. rer. nat. Tobias Bopp
Institut für Immunologie Forschungszentrum Immuntherapie
Mainz
boppt@uni-mainz.de

News

Mon, 20/09/2021
Register now: 1st Symposium inflammation and imaging
When?: from November 2nd to November 4th 2021 Where?: Schloss (seat of the University Administration) Muenster Organizers: Co-operative Research Centres 1009, 1450, Transregio 128, and Clinical Research Unit 342 – together with Interdisciplinary Centre of Clinical Research (IZKF) and Excellence Cluster Cells in Motion (CiM) Registration is open now! More information: here...more
Mon, 09/08/2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent years. This so-called gut-CNS axis can be shaped by dietary factors, either directly or via indirect modulation of the gut microbiome and its metabolites. Here, SFB 128 PI Luisa Klotz and colleagues report […]...more
Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more